Page last updated: 2024-11-08

alanine and Multiple Endocrine Neoplasia Type 1

alanine has been researched along with Multiple Endocrine Neoplasia Type 1 in 1 studies

Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.

Multiple Endocrine Neoplasia Type 1: A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).

Research Excerpts

ExcerptRelevanceReference
"We report a multiple endocrine neoplasia type 1 (MEN1) patient associated with carcinoid syndrome."1.32A novel missense mutation of the MEN1 gene in a multiple endocrine neoplasia type 1 patient associated with carcinoid syndrome. ( Nishikawa, M; Shigeta, H; Tanaka, T; Ukita, C; Yamaguchi, M, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ukita, C1
Yamaguchi, M1
Tanaka, T1
Shigeta, H1
Nishikawa, M1

Other Studies

1 other study available for alanine and Multiple Endocrine Neoplasia Type 1

ArticleYear
A novel missense mutation of the MEN1 gene in a multiple endocrine neoplasia type 1 patient associated with carcinoid syndrome.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:11

    Topics: Alanine; Carcinoid Tumor; DNA Mutational Analysis; Duodenal Neoplasms; Female; Fluorescence; Humans;

2003